Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FLAC

Frazier LifeSciences Acq... (FLAC)

Frazier LifeSciences Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FLAC
DateTimeSourceHeadlineSymbolCompany
02/15/202310:15AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
12/02/20224:32PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
12/01/20224:52PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/25/20221:44PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/23/20224:37PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/23/20224:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/23/20224:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/23/20224:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/23/20224:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/23/20228:00AMGlobeNewswire Inc.NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular DiseaseNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/22/20224:17PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/22/20224:16PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/15/202211:31AMBusiness WireFrazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/14/20226:13PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/09/20224:07PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
11/04/20226:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
10/13/20225:02PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
10/05/20224:17PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
10/04/20224:17PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/28/20225:31PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/26/20228:00AMGlobeNewswire Inc.Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of DirectorsNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/23/20224:17PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/20/20224:31PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
09/20/20226:07AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
08/29/20224:16PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
08/24/20225:04PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
08/19/20225:01PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
08/17/20224:32PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
08/16/20225:07PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
08/11/20225:28PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:FLAC